Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2010-01-06

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3233/JAD-2010-1239PMID 20061651PMCID PMC2842004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer disease.

  2010cited by this paper
• The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha

  2009cited by this paper
• Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.

  2009cited by this paper
• Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

  2009cited by this paper
• The up‐regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α

  2009cited by this paper
• Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

  2008cited by this paper
• Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

  2008cited by this paper
• Mild Cognitive Impairment and Alzheimer Patients Display Different Levels of Redox-Active CSF Iron

  2008cited by this paper
• The cerebellum in mild cognitive impairment and Alzheimer's disease - a structural MRI study.

  2008cited by this paper
• Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.

  2008cited by this paper
• Drug Development Based on the Metals Hypothesis of Alzheimer's Disease

  2008cited by this paper
• Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein.

  2008cited by this paper
• Autophagocytosis of Mitochondria Is Prominent in Alzheimer Disease

  2007cited by this paper
• Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease

  2007cited by this paper
• Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein

  2007cited by this paper
• Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease

  2007cited by this paper
• Dementia : an atlas of investigation and diagnosis

  2007influential reference
• Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide.

  2007cited by this paper
• Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder

  2007cited by this paper
• Oxidative damage in mild cognitive impairment and early Alzheimer's disease

  2007cited by this paper
• Lipoic Acid and N-acetyl Cysteine Decrease Mitochondrial-Related Oxidative Stress in Alzheimer Disease Patient Fibroblasts

  2007cited by this paper
• Alzheimer disease, the two-hit hypothesis: an update.

  2007cited by this paper
• Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide

  2007cited by this paper
• Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron.

  2007cited by this paper
• Amyloid beta: the alternate hypothesis.

  2006cited by this paper
• Neuropathology of Alzheimer disease: pathognomonic but not pathogenic

  2006cited by this paper
• Tau protein, the main component of paired helical filaments

  2006cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal.

  2006cited by this paper
• Progress from Alzheimer's tangles to pathological tau points towards more effective therapies now

  2006cited by this paper
• Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment.

  2006cited by this paper
• Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau

  2006cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

  2006cited by this paper
• Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.

  2006cited by this paper
• Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease

  2006cited by this paper
• Oxidative stress and iron imbalance in Alzheimer disease: How rust became the fuss!

  2006cited by this paper
• Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.

  2006cited by this paper
• Tau phosphorylation in Alzheimer's disease: pathogen or protector?

  2005cited by this paper
• Are mitochondria critical in the pathogenesis of Alzheimer's disease?

  2005cited by this paper
• Evidence of increased oxidative damage in subjects with mild cognitive impairment

  2005cited by this paper
• Nanoparticle and other metal chelation therapeutics in Alzheimer disease.

  2005cited by this paper
• Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients.

  2005cited by this paper
• Alzheimer's disease: the two-hit hypothesis

  2004cited by this paper
• Oxidative stress in mild cognitive impairment and Alzheimer disease: A continuum

  2004cited by this paper
• Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients

  2004cited by this paper
• Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

  2004cited by this paper
• Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

  2004cited by this paper
• Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

  2003cited by this paper
• Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.

  2003cited by this paper
• A Metabolic Basis for Alzheimer Disease

  2003cited by this paper
• Neuronal Death versus Synaptic Pathology in Alzheimer's Disease

  2003cited by this paper
• Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain

  2002cited by this paper
• Amyloid-β: redox-metal chelator and antioxidant

  2002cited by this paper
• Amyloid-beta: redox-metal chelator and antioxidant.

  2002cited by this paper
• Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.

  2002cited by this paper
• Cell cycle proteins in Alzheimer's disease: Plenty of wheels but no cycle

  2002cited by this paper
• Oxidative stress increases expression and activity of BACE in NT2 neurons.

  2002cited by this paper
• Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

  2002cited by this paper
• Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.

  2002cited by this paper
• Chemistry and biochemistry of oxidative stress in neurodegenerative disease.

  2001cited by this paper
• Redox-active iron mediates amyloid-β toxicity

  2001cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine

  2001cited by this paper
• Absence of cognitive impairment or decline in preclinical Alzheimer’s disease

  2001influential reference
• Redox-active iron mediates amyloid-beta toxicity.

  2001cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• Oxidative damage in Alzheimer's disease: the metabolic dimension

  2000cited by this paper
• Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc*

  2000cited by this paper
• Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.

  2000cited by this paper
• In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

  2000influential reference
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999cited by this paper
• Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease.

  1999cited by this paper
• Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease

  1999influential reference
• Diet and Oxidative Stress: A Novel Synthesis of Epidemiological Data on Alzheimer's Disease

  1999cited by this paper
• Dietary Links to Alzheimer's Disease: 1999 Update

  1999cited by this paper
• Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

  1999cited by this paper
• Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine

  1998cited by this paper
• Early glycoxidation damage in brains from Down's syndrome.

  1998cited by this paper
• Abnormal localization of iron regulatory protein in Alzheimer's disease.

  1998cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• Oxidative stress and lymphocytes in Alzheimer disease

  1998cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997influential reference
• Dietary Links to Alzheimer's Disease

  1997cited by this paper
• Inherent abnormalities in oxidative metabolism in Alzheimer's disease: interaction with vascular abnormalities.

  1997cited by this paper
• Impaired dynamic morphology of cerebellar mitochondria in physiological aging and Alzheimer's disease.

  1997cited by this paper
• Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

  1997cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

  1996cited by this paper
• Brain samples from Alzheimer's patients have elevated levels of loosely bound iron.

  1996cited by this paper
• Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.

  1996cited by this paper
• Early AGEing and Alzheimer's

  1995cited by this paper
• Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide

  1995cited by this paper
• A tombstone in Alzheimer's?

  1995cited by this paper
• Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain

  1995cited by this paper
• Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease

  1995cited by this paper
• Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease

  1995cited by this paper
• Alzheimer Disease

  1994cited by this paper
• Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

  1994cited by this paper
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease

  1992cited by this paper

• Ferroptosis and Alzheimer's disease: a new insight into neurodegeneration.

  2026cites this paper
• Ferroptosis and Alzheimer’s disease: unraveling the molecular mechanisms and therapeutic opportunities

  2026cites this paper
• Prefrontal cortex iron content in neurodegeneration and healthy subjects: A systematic review

  2025influential citation
• Carbon ion stimulation therapy reverses iron deposits and microglia driven neuroinflammation and induces cognitive improvement in an Alzheimer’s disease mouse model

  2025cites this paper
• Insights into targeted ferroptosis in mechanisms, biology, and role of Alzheimer's disease: an update

  2025cites this paper
• 3-Hydroxyquinolin-2-Ones Act as Dual Inhibitors of Ferroptosis and Monoamine Oxidase B: Reducing Alzheimer's Disease-Related Amyloid Precursor Protein and Hyperphosphorylated Tau In Vivo.

  2025cites this paper
• Pulling back the mitochondria’s iron curtain

  2025cites this paper
• A Sequentially activated probe for simultaneous fluorescence imaging of ONOO― and HOBr in brain to indicate Alzheimer’s Disease

  2025cites this paper
• Brain iron accumulation in neurodegenerative disorders: Does air pollution play a role?

  2025cites this paper
• Multi-omics analyses of early-onset familial Alzheimer's disease and Sanfilippo syndrome zebrafish models reveal commonalities in disease mechanisms.

  2025cites this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies

  2025cites this paper
• Associations Between Cortical Iron Accumulation and Memory in Patients With Amnestic Mild Cognitive Impairment and in Cognitively Normal Individuals

  2025cites this paper
• Management of Alzheimer's Disease Through Nutrition

  2025cites this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases

  2025cites this paper
• Differential DNA methylation in blood in nuclear genes that encode mitochondrial proteins in mild cognitive impairment and Alzheimer’s disease

  2025cites this paper
• Association between cognitive function and relaxation rates of the cerebral cortex.

  2025cites this paper
• Blood-based biomarkers in mild behavioral impairment: an updated overview

  2025cites this paper
• Carbon nanotube field-effect transistor immunosensor for the real-time detection of serum ferritin, a biomarker of Alzheimer's disease

  2025cites this paper
• The interplay of oxidative stress and neurodegeneration: Nanoantioxidants as a novel therapeutic approach

  2025cites this paper
• Modulating Mitochondrial Dynamics Preserves Cognitive Performance via Ameliorating Iron-Mediated Brain Toxicity in Iron-Overload Rats.

  2025cites this paper
• Iron Homeostasis Dysregulation, Oro-Gastrointestinal Microbial Inflammatory Factors, and Alzheimer’s Disease: A Narrative Review

  2025cites this paper
• Peroxynitrite activated near-infrared fluorescent probe for fluorescence and afterglow imaging of Alzheimer's disease brain

  2025cites this paper
• The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects.

  2024cites this paper
• Investigating the oxidative stress–vascular brain injury axis in mild cognitive impairment of the Alzheimer's type

  2024cites this paper
• Identification and immunological characterization of genes associated with ferroptosis in Alzheimer's disease and experimental demonstration

  2024cites this paper
• Ferroptosis and pathogenesis of neuritic plaques in Alzheimer's Disease.

  2024cites this paper
• Brain Iron Dyshomeostasis and Ferroptosis in Alzheimer’s Disease Pathophysiology: Two Faces of the Same Coin

  2024cites this paper
• Effect of Hydrogen Bonding Network on Raman Modes of Methanol–Hydrogen Peroxide Binary Solutions

  2024cites this paper
• Fluorescent probes for sensing peroxynitrite: biological applications

  2024cites this paper
• E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.

  2024cites this paper
• Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged mice.

  2024cites this paper
• Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer’s Disease Is Associated with Activation of HIF-1 Signaling Pathway

  2024cites this paper
• Exploring Potential Mechanisms Accounting for Iron Accumulation in the Central Nervous System of Patients with Alzheimer’s Disease

  2024influential citation
• Ferroptosis: A New Strategy for Targeting Alzheimer's Disease.

  2024cites this paper
• Loss of calcium/calmodulin-dependent protein kinase kinase 2, transferrin, and transferrin receptor proteins in the temporal cortex of Alzheimer’s patients postmortem is associated with abnormal iron homeostasis: implications for patient survival

  2024cites this paper
• Association of waist-to-hip ratio adjusted for body mass index with cognitive impairment in middle-aged and elderly patients with type 2 diabetes mellitus: a cross-sectional study

  2024cites this paper
• Ferroptosis: Implications in Diseases and Potential Treatment Approaches

  2024cites this paper
• Cerebellum in neurodegenerative diseases: Advances, challenges, and prospects

  2024cites this paper
• A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4

  2024cites this paper
• Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease

  2024cites this paper
• Mitochondria-targeted nanotherapeutics: A new Frontier in neurodegenerative disease treatment.

  2024cites this paper
• Rlip76 in ageing and Alzheimer's disease: Focus on oxidative stress and mitochondrial mechanisms.

  2024cites this paper
• Driving factors of neuronal ferroptosis.

  2024cites this paper
• Distribution of Iron, Copper, Zinc and Cadmium in Glia, Their Influence on Glial Cells and Relationship with Neurodegenerative Diseases

  2023cites this paper
• The common marmoset as a model of neurodegeneration.

  2023cites this paper
• Dietary Components and Nutritional Strategies for Dementia Prevention in the Elderly.

  2023cites this paper
• Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.

  2023cites this paper
• Potential Role of Oxidative Stress in the Effects of Chronic Administration of Iron on Affective and Cognitive Behavior on Male Wistar Rat

  2023cites this paper
• Future foods, dietary factors and healthspan

  2023cites this paper
• Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

  2023cites this paper
• The Neuroprotective Effect of Ginsenoside Rb1 on the Cerebral Cortex Changes Induced by Aluminium Chloride in a Mouse Model of Alzheimer's Disease: A Histological, Immunohistochemical, and Biochemical Study.

  2023cites this paper
• Altered brain iron deposition in patients with minimal hepatic encephalopathy: an MRI quantitative susceptibility mapping study.

  2023cites this paper
• The Role of Iron Metabolism in Sepsis-associated Encephalopathy: a Potential Target

  2023cites this paper
• Programmed Death of Microglia in Alzheimer’s Disease: Autophagy, Ferroptosis, and Pyroptosis

  2023cites this paper
• Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer's disease.

  2023cites this paper
• Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer’s Disease

  2023cites this paper
• Effect of oxidative stress on microglial activation and iron accumulation

  2023cites this paper
• In Silico Analysis Reveals the Modulation of Ion Transmembrane Transporters in the Cerebellum of Alzheimer’s Disease Patients

  2023cites this paper
• Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities

  2023cites this paper
• Slingshot homolog-1–mediated Nrf2 sequestration tips the balance from neuroprotection to neurodegeneration in Alzheimer’s disease

  2023cites this paper
• The role of microbiome-host interactions in the development of Alzheimer´s disease

  2023cites this paper
• Brain iron deposition is positively correlated with cognitive impairment in patients with chronic cerebral hypoperfusion: a MRI susceptibility mapping study.

  2023cites this paper
• Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease

  2023cites this paper
• Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer's Disease: Critical role of the restoration of neuronal circuits.

  2023cites this paper
• Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals

  2022cites this paper
• Ferroptosis: a potential therapeutic target for Alzheimer’s disease

  2022cites this paper
• Cognition and brain iron deposition in whole grey matter regions and hippocampal subfields

  2022cites this paper
• Is microglial dystrophy a form of cellular senescence? An analysis of senescence markers in the aged human brain

  2022cites this paper
• Iron overload and neurodegenerative diseases: What can we learn from Caenorhabditis elegans?

  2022cites this paper
• An Activity-Based Fluorescent Probe for Imaging Fluctuations of Peroxynitrite (ONOO-) in the Alzheimer's Disease Brain.

  2022cites this paper
• Iron and Alzheimer’s Disease: From Pathology to Imaging

  2022cites this paper
• Ferroptosis involved in sevoflurane-aggravated young rats brain injury induced by liver transplantation

  2022cites this paper
• New Insights into the Molecular Interplay between Human Herpesviruses and Alzheimer’s Disease—A Narrative Review

  2022cites this paper
• Protein misfolding and related human diseases: A comprehensive review of toxicity, proteins involved, and current therapeutic strategies.

  2022cites this paper
• Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?

  2022cites this paper
• Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer’s Disease

  2022cites this paper
• Discovery and validation of Ferroptosis-related molecular patterns and immune characteristics in Alzheimer’s disease

  2022cites this paper
• Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities

  2022influential citation
• Trace concentrations, heavy implications: Influences of biometals on major brain pathologies of Alzheimer's disease.

  2021cites this paper
• RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease

  2021influential citation
• Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation

  2021cites this paper
• Alzheimer’s Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound

  2021cites this paper
• Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease

  2021cites this paper
• Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease

  2021cites this paper
• Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease

  2021cites this paper
• B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment

  2021cites this paper
• Iron Overload-Induced Oxidative Stress in Myelodysplastic Syndromes and its Cellular Sequelae.

  2021cites this paper
• A Review on Lactoferrin and Central Nervous System Diseases

  2021cites this paper
• Supplementation with ribonucleotide-based ingredient (Ribodiet®) lessens oxidative stress, brain inflammation, and amyloid pathology in a murine model of Alzheimer.

  2021cites this paper
• The oxidatively damaged DNA and amyloid-β oligomer hypothesis of Alzheimer's disease?

  2021cites this paper
• The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis

  2021influential citation
• Melatonin ameliorates cognitive deficits through improving mitophagy in a mouse model of Alzheimer’s disease

  2021cites this paper
• Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology

  2021cites this paper
• Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease

  2021cites this paper
• Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target

  2021cites this paper
• Theranostics

  2021cites this paper
• Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer’s Disease

  2021cites this paper
• Prolific shedding of magnetite nanoparticles from banknote surfaces.

  2021cites this paper
• Iron and Ferroptosis as Therapeutic Targets in Alzheimer’s Disease

  2020cites this paper
• Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy.

  2020cites this paper